Department of Internal Medicine, Section Pharmacotherapy, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands
Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, The Netherlands.
BMJ Open. 2021 May 4;11(5):e045635. doi: 10.1136/bmjopen-2020-045635.
Junior doctors are responsible for a substantial number of prescribing errors, and final-year medical students lack sufficient prescribing knowledge and skills just before they graduate. Various national and international projects have been initiated to reform the teaching of clinical pharmacology and therapeutics (CP&T) during undergraduate medical training. However, there is as yet no list of commonly prescribed and available medicines that European doctors should be able to independently prescribe safely and effectively without direct supervision. Such a list could form the basis for a European Prescribing Exam and would harmonise European CP&T education. Therefore, the aim of this study is to reach consensus on a list of widely prescribed medicines, available in most European countries, that European junior doctors should be able to independently prescribe safely and effectively without direct supervision: the European List of Essential Medicines for Medical Education.
This modified Delphi study will recruit European CP&T teachers (expert group). Two Delphi rounds will be carried out to enable a list to be drawn up of medicines that are available in ≥80% of European countries, which are considered standard prescribing practice, and which junior doctors should be able to prescribe safely and effectively without supervision.
The study has been approved by the Medical Ethics Review Committee of VU University Medical Center (no. 2020.335) and by the Ethical Review Board of the Netherlands Association for Medical Education (approved project no. NVMO-ERB 2020.4.8). The European List of Essential Medicines for Medical Education will be presented at national and international conferences and will be submitted to international peer-reviewed journals. It will also be used to develop and implement the European Prescribing Exam.
初级医生要对大量的处方错误负责,而且即将毕业的医学生在毕业前缺乏足够的处方知识和技能。为了改革本科医学培训期间的临床药理学和治疗学(CP&T)教学,已经启动了各种国家和国际项目。然而,目前还没有一份欧洲医生在没有直接监督的情况下能够安全有效地独立开处方的常用处方药物和可获得药物的清单。这样的清单可以作为欧洲处方考试的基础,并使欧洲的 CP&T 教育协调一致。因此,本研究的目的是就一份广泛开处方的、大多数欧洲国家都可获得的、欧洲初级医生在没有直接监督的情况下能够安全有效地独立开处方的药物清单达成共识:即欧洲医学教育基本药物清单。
这项经过修改的德尔菲研究将招募欧洲 CP&T 教师(专家组)。将进行两轮德尔菲调查,以制定一份在≥80%的欧洲国家都有供应的药物清单,这些药物被认为是标准的处方实践,初级医生在没有监督的情况下能够安全有效地开具这些药物。
该研究已获得 VU 大学医学中心医学伦理审查委员会(编号 2020.335)和荷兰医学教育协会伦理审查委员会(批准项目编号 NVMO-ERB 2020.4.8)的批准。欧洲医学教育基本药物清单将在国家和国际会议上展示,并提交给国际同行评议期刊。它也将用于开发和实施欧洲处方考试。